PortfoliosLab logoPortfoliosLab logo
CVKD vs. FLEX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CVKD vs. FLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cadrenal Therapeutics Inc. Common Stock (CVKD) and Flex Ltd. (FLEX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CVKD achieves a -53.10% return, which is significantly lower than FLEX's 157.88% return.


CVKD

1D
-9.14%
1M
-38.73%
YTD
-53.10%
6M
-57.80%
1Y
-74.25%
3Y*
-49.02%
5Y*
10Y*

FLEX

1D
5.56%
1M
17.62%
YTD
157.88%
6M
144.29%
1Y
238.50%
3Y*
120.18%
5Y*
74.99%
10Y*
36.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CVKD vs. FLEX - Yearly Performance Comparison


2026 (YTD)202520242023
CVKD
Cadrenal Therapeutics Inc. Common Stock
-53.10%-53.21%30.56%-87.04%
FLEX
Flex Ltd.
157.88%57.38%127.87%28.96%

Correlation

The correlation between CVKD and FLEX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jan 20, 2023

0.17

Fundamentals

Market Cap

CVKD:

$6.34M

FLEX:

$58.27B

EPS

CVKD:

-$5.10

FLEX:

$2.33

PB Ratio

CVKD:

2.31

FLEX:

11.33

Total Revenue (TTM)

CVKD:

$0.00

FLEX:

$27.91B

Gross Profit (TTM)

CVKD:

-$5.92K

FLEX:

$2.57B

EBITDA (TTM)

CVKD:

-$13.32M

FLEX:

$1.66B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CVKD vs. FLEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVKD
CVKD Risk / Return Rank: 77
Overall Rank
CVKD Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
CVKD Sortino Ratio Rank: 88
Sortino Ratio Rank
CVKD Omega Ratio Rank: 1111
Omega Ratio Rank
CVKD Calmar Ratio Rank: 44
Calmar Ratio Rank
CVKD Martin Ratio Rank: 22
Martin Ratio Rank

FLEX
FLEX Risk / Return Rank: 9797
Overall Rank
FLEX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
FLEX Sortino Ratio Rank: 9797
Sortino Ratio Rank
FLEX Omega Ratio Rank: 9696
Omega Ratio Rank
FLEX Calmar Ratio Rank: 9999
Calmar Ratio Rank
FLEX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CVKD vs. FLEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cadrenal Therapeutics Inc. Common Stock (CVKD) and Flex Ltd. (FLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CVKDFLEXDifference
Sharpe ratioReturn per unit of total volatility

-4.64

Sortino ratioReturn per unit of downside risk

-5.84

Omega ratioGain probability vs. loss probability

0.86

1.59

-0.73

Calmar ratioReturn relative to maximum drawdown

-0.95

13.06

-14.01

Martin ratioReturn relative to average drawdown

-1.75

30.58

-32.33

CVKD vs. FLEX - Sharpe Ratio Comparison

The current CVKD Sharpe Ratio is -0.74, which is lower than the FLEX Sharpe Ratio of 3.89. The chart below compares the historical Sharpe Ratios of CVKD and FLEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CVKD vs. FLEX - Drawdown Comparison

The maximum CVKD drawdown since its inception was -96.45%, roughly equal to the maximum FLEX drawdown of -96.37%. Use the drawdown chart below to compare losses from any high point for CVKD and FLEX.


Loading charts...

Drawdown Indicators


CVKDFLEXDifference

Max Drawdown

Largest peak-to-trough decline

-96.45%

-96.37%

-0.08%

Max Drawdown (1Y)

Largest decline over 1 year

-78.59%

-18.38%

-60.21%

Max Drawdown (3Y)

Largest decline over 3 years

-90.99%

-39.99%

-51.00%

Max Drawdown (5Y)

Largest decline over 5 years

-39.99%

Max Drawdown (10Y)

Largest decline over 10 years

-70.02%

Current Drawdown

Current decline from peak

-96.29%

-3.79%

-92.50%

Average Drawdown

Average peak-to-trough decline

-84.77%

-55.24%

-29.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

42.39%

7.84%

+34.55%

Volatility

CVKD vs. FLEX - Volatility Comparison

Cadrenal Therapeutics Inc. Common Stock (CVKD) has a higher volatility of 26.09% compared to Flex Ltd. (FLEX) at 18.18%. This indicates that CVKD's price experiences larger fluctuations and is considered to be riskier than FLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CVKDFLEXDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.09%

18.18%

+7.91%

Volatility (6M)

Calculated over the trailing 6-month period

68.56%

50.42%

+18.14%

Volatility (1Y)

Calculated over the trailing 1-year period

100.24%

61.82%

+38.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

102.28%

47.33%

+54.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

102.28%

45.93%

+56.35%

Dividends

CVKD vs. FLEX - Dividend Comparison

Neither CVKD nor FLEX has paid dividends to shareholders.


PositionTTM20252024
CVKD
Cadrenal Therapeutics Inc. Common Stock
0.00%0.00%0.00%
FLEX
Flex Ltd.
0.00%0.00%21.00%

Financials

CVKD vs. FLEX - Financials Comparison

This section allows you to compare key financial metrics between Cadrenal Therapeutics Inc. Common Stock and Flex Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
7.48B
(CVKD) Total Revenue
(FLEX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CVKD and FLEX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CVKD has higher volatility (26.09%) compared to FLEX (18.18%). In terms of maximum drawdown, CVKD dropped -96.45% vs FLEX's -96.37%.

FLEX currently has the higher Sharpe Ratio (3.89 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CVKD and FLEX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer